Development of phage resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates

Antimicrobial resistance (AMR) is an escalating global health threat, attributable to the diminishing availability of efficient antibiotics against bacterial infections. Phage therapy is considered an alternative therapeutic solution to treat resistant infections. In phage therapy, the bacteria are...

Full description

Bibliographic Details
Main Author: Vacker, Sanna
Other Authors: Faculty of Sciences, Matemaattis-luonnontieteellinen tiedekunta, Department of Biological and Environmental Science, Bio- ja ympäristötieteiden laitos, University of Jyväskylä, Jyväskylän yliopisto
Format: Master's thesis
Language:eng
Published: 2024
Subjects:
Online Access: https://jyx.jyu.fi/handle/123456789/94585
_version_ 1826225690002849792
author Vacker, Sanna
author2 Faculty of Sciences Matemaattis-luonnontieteellinen tiedekunta Department of Biological and Environmental Science Bio- ja ympäristötieteiden laitos University of Jyväskylä Jyväskylän yliopisto
author_facet Vacker, Sanna Faculty of Sciences Matemaattis-luonnontieteellinen tiedekunta Department of Biological and Environmental Science Bio- ja ympäristötieteiden laitos University of Jyväskylä Jyväskylän yliopisto Vacker, Sanna Faculty of Sciences Matemaattis-luonnontieteellinen tiedekunta Department of Biological and Environmental Science Bio- ja ympäristötieteiden laitos University of Jyväskylä Jyväskylän yliopisto
author_sort Vacker, Sanna
datasource_str_mv jyx
description Antimicrobial resistance (AMR) is an escalating global health threat, attributable to the diminishing availability of efficient antibiotics against bacterial infections. Phage therapy is considered an alternative therapeutic solution to treat resistant infections. In phage therapy, the bacteria are treated with phages, which are natural viruses that infect bacteria. However, the development of phage resistance in bacterial communities can be affected by various host-associated factors. Mucin is a glycoprotein found in the mucosal layer of the human gut, which primarily protects the cellular surface. The interactions between bacteria and phages often occur in the mucous membrane. Also, recent studies have found the potential of mucin to alter phage-bacteria interactions. In this research, the evolution of phage resistance in Escherichia coli and Klebsiella pneumoniae strains was studied in the presence of mucin and antibiotics. First, bacterial growth was measured under various mucin and antibiotic concentrations in the absence of phage to select optimal conditions for the evolution experiment. In the evolution experiment, ESBL-producing E. coli and K. pneumoniae strains were sequentially exposed to phages, one at a time, in the presence of tetracycline and/or mucin. After the experiment, the development of phage resistance was tested in the exposed bacteria by a co-culture experiment. The results demonstrate that the phage-treated bacteria exhibited consistent development of phage resistance compared to the original strains. In an effort to develop efficient phage therapy, the findings of this research help comprehend the potential factors that may hamper the successful treatment of bacterial infections.
first_indexed 2024-04-30T20:00:45Z
format Pro gradu
fullrecord [{"key": "dc.contributor.advisor", "value": "Penttinen, Reetta", "language": null, "element": "contributor", "qualifier": "advisor", "schema": "dc"}, {"key": "dc.contributor.advisor", "value": "Jonsdottir, Ilmur", "language": null, "element": "contributor", "qualifier": "advisor", "schema": "dc"}, {"key": "dc.contributor.author", "value": "Vacker, Sanna", "language": null, "element": "contributor", "qualifier": "author", "schema": "dc"}, {"key": "dc.date.accessioned", "value": "2024-04-30T07:01:43Z", "language": null, "element": "date", "qualifier": "accessioned", "schema": "dc"}, {"key": "dc.date.available", "value": "2024-04-30T07:01:43Z", "language": null, "element": "date", "qualifier": "available", "schema": "dc"}, {"key": "dc.date.issued", "value": "2024", "language": null, "element": "date", "qualifier": "issued", "schema": "dc"}, {"key": "dc.identifier.uri", "value": "https://jyx.jyu.fi/handle/123456789/94585", "language": null, "element": "identifier", "qualifier": "uri", "schema": "dc"}, {"key": "dc.description.abstract", "value": "Antimicrobial resistance (AMR) is an escalating global health threat, attributable to the diminishing availability of efficient antibiotics against bacterial infections. Phage therapy is considered an alternative therapeutic solution to treat resistant infections. In phage therapy, the bacteria are treated with phages, which are natural viruses that infect bacteria. However, the development of phage resistance in bacterial communities can be affected by various host-associated factors. Mucin is a glycoprotein found in the mucosal layer of the human gut, which primarily protects the cellular surface. The interactions between bacteria and phages often occur in the mucous membrane. Also, recent studies have found the potential of mucin to alter phage-bacteria interactions. In this research, the evolution of phage resistance in Escherichia coli and Klebsiella pneumoniae strains was studied in the presence of mucin and antibiotics. First, bacterial growth was measured under various mucin and antibiotic concentrations in the absence of phage to select optimal conditions for the evolution experiment. In the evolution experiment, ESBL-producing E. coli and K. pneumoniae strains were sequentially exposed to phages, one at a time, in the presence of tetracycline and/or mucin. After the experiment, the development of phage resistance was tested in the exposed bacteria by a co-culture experiment. The results demonstrate that the phage-treated bacteria exhibited consistent development of phage resistance compared to the original strains. In an effort to develop efficient phage therapy, the findings of this research help comprehend the potential factors that may hamper the successful treatment of bacterial infections.", "language": "fi", "element": "description", "qualifier": "abstract", "schema": "dc"}, {"key": "dc.description.provenance", "value": "Submitted by Paivi Vuorio (paelvuor@jyu.fi) on 2024-04-30T07:01:43Z\nNo. of bitstreams: 0", "language": "en", "element": "description", "qualifier": "provenance", "schema": "dc"}, {"key": "dc.description.provenance", "value": "Made available in DSpace on 2024-04-30T07:01:43Z (GMT). No. of bitstreams: 0\n Previous issue date: 2024", "language": "en", "element": "description", "qualifier": "provenance", "schema": "dc"}, {"key": "dc.format.extent", "value": "61", "language": "", "element": "format", "qualifier": "extent", "schema": "dc"}, {"key": "dc.format.mimetype", "value": "application/pdf", "language": null, "element": "format", "qualifier": "mimetype", "schema": "dc"}, {"key": "dc.language.iso", "value": "eng", "language": null, "element": "language", "qualifier": "iso", "schema": "dc"}, {"key": "dc.rights", "value": "In Copyright", "language": "en", "element": "rights", "qualifier": null, "schema": "dc"}, {"key": "dc.subject.other", "value": "mucin", "language": "", "element": "subject", "qualifier": "other", "schema": "dc"}, {"key": "dc.subject.other", "value": "tetracycline", "language": "", "element": "subject", "qualifier": "other", "schema": "dc"}, {"key": "dc.title", "value": "Development of phage resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates", "language": null, "element": "title", "qualifier": null, "schema": "dc"}, {"key": "dc.type", "value": "master thesis", "language": null, "element": "type", "qualifier": null, "schema": "dc"}, {"key": "dc.identifier.urn", "value": "URN:NBN:fi:jyu-202404303213", "language": null, "element": "identifier", "qualifier": "urn", "schema": "dc"}, {"key": "dc.type.ontasot", "value": "Master\u2019s thesis", "language": "en", "element": "type", "qualifier": "ontasot", "schema": "dc"}, {"key": "dc.type.ontasot", "value": "Pro gradu -tutkielma", "language": "fi", "element": "type", "qualifier": "ontasot", "schema": "dc"}, {"key": "dc.contributor.faculty", "value": "Faculty of Sciences", "language": "en", "element": "contributor", "qualifier": "faculty", "schema": "dc"}, {"key": "dc.contributor.faculty", "value": "Matemaattis-luonnontieteellinen tiedekunta", "language": "fi", "element": "contributor", "qualifier": "faculty", "schema": "dc"}, {"key": "dc.contributor.department", "value": "Department of Biological and Environmental Science", "language": "en", "element": "contributor", "qualifier": "department", "schema": "dc"}, {"key": "dc.contributor.department", "value": "Bio- ja ymp\u00e4rist\u00f6tieteiden laitos", "language": "fi", "element": "contributor", "qualifier": "department", "schema": "dc"}, {"key": "dc.contributor.organization", "value": "University of Jyv\u00e4skyl\u00e4", "language": "en", "element": "contributor", "qualifier": "organization", "schema": "dc"}, {"key": "dc.contributor.organization", "value": "Jyv\u00e4skyl\u00e4n yliopisto", "language": "fi", "element": "contributor", "qualifier": "organization", "schema": "dc"}, {"key": "dc.subject.discipline", "value": "Cell and molecular biology", "language": "en", "element": "subject", "qualifier": "discipline", "schema": "dc"}, {"key": "dc.subject.discipline", "value": "Solu- ja molekyylibiologia", "language": "fi", "element": "subject", "qualifier": "discipline", "schema": "dc"}, {"key": "yvv.contractresearch.funding", "value": "0", "language": "", "element": "contractresearch", "qualifier": "funding", "schema": "yvv"}, {"key": "dc.type.coar", "value": "http://purl.org/coar/resource_type/c_bdcc", "language": null, "element": "type", "qualifier": "coar", "schema": "dc"}, {"key": "dc.rights.copyright", "value": "\u00a9 The Author(s)", "language": null, "element": "rights", "qualifier": "copyright", "schema": "dc"}, {"key": "dc.rights.accesslevel", "value": "restrictedAccess", "language": null, "element": "rights", "qualifier": "accesslevel", "schema": "dc"}, {"key": "dc.type.publication", "value": "masterThesis", "language": null, "element": "type", "qualifier": "publication", "schema": "dc"}, {"key": "dc.subject.oppiainekoodi", "value": "4013", "language": null, "element": "subject", "qualifier": "oppiainekoodi", "schema": "dc"}, {"key": "dc.subject.yso", "value": "biofilmit", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "evoluutio", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "bakteerit", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "antibiootit", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "infektiot", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "biofilms", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "evolution", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "bacteria", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "antibiotics", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "infections", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.format.content", "value": "fulltext", "language": null, "element": "format", "qualifier": "content", "schema": "dc"}, {"key": "dc.rights.url", "value": "https://rightsstatements.org/page/InC/1.0/", "language": null, "element": "rights", "qualifier": "url", "schema": "dc"}, {"key": "dc.rights.accessrights", "value": "The author has not given permission to make the work publicly available electronically. Therefore the material can be read only at the archival workstation at Jyv\u00e4skyl\u00e4 University Library (https://kirjasto.jyu.fi/en/workspaces/facilities/facilities#autotoc-item-autotoc-2).", "language": "en", "element": "rights", "qualifier": "accessrights", "schema": "dc"}, {"key": "dc.rights.accessrights", "value": "Tekij\u00e4 ei ole antanut lupaa avoimeen julkaisuun, joten aineisto on luettavissa vain Jyv\u00e4skyl\u00e4n yliopiston kirjaston arkistoty\u00f6semalta. Ks. https://kirjasto.jyu.fi/fi/tyoskentelytilat/laitteet-ja-tilat#autotoc-item-autotoc-2.", "language": "fi", "element": "rights", "qualifier": "accessrights", "schema": "dc"}]
id jyx.123456789_94585
language eng
last_indexed 2025-02-18T10:54:57Z
main_date 2024-01-01T00:00:00Z
main_date_str 2024
publishDate 2024
record_format qdc
source_str_mv jyx
spellingShingle Vacker, Sanna Development of phage resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates mucin tetracycline Cell and molecular biology Solu- ja molekyylibiologia 4013 biofilmit evoluutio bakteerit antibiootit infektiot biofilms evolution bacteria antibiotics infections
title Development of phage resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates
title_full Development of phage resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates
title_fullStr Development of phage resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates Development of phage resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates
title_full_unstemmed Development of phage resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates Development of phage resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates
title_short Development of phage resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates
title_sort development of phage resistance in clinical escherichia coli and klebsiella pneumoniae isolates
title_txtP Development of phage resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates
topic mucin tetracycline Cell and molecular biology Solu- ja molekyylibiologia 4013 biofilmit evoluutio bakteerit antibiootit infektiot biofilms evolution bacteria antibiotics infections
topic_facet 4013 Cell and molecular biology Solu- ja molekyylibiologia antibiootit antibiotics bacteria bakteerit biofilmit biofilms evolution evoluutio infections infektiot mucin tetracycline
url https://jyx.jyu.fi/handle/123456789/94585 http://www.urn.fi/URN:NBN:fi:jyu-202404303213
work_keys_str_mv AT vackersanna developmentofphageresistanceinclinicalescherichiacoliandklebsiellapneumoniaeisolates